Core Biotherapeutics

Dina Gonzalez, MBA

Chief Financial Officer

Dina has served as Chief Financial Officer of Core Biotherapeutics, bringing extensive experience in financial operations, accounting, corporate governance, and biotechnology transactions. Previously, she was Corporate Controller at Adynxx, where she established the company’s finance, accounting, and human resources functions and managed financial operations through its reverse merger with Alliqua Biomedical. Earlier, she served as Corporate Controller at Corthera, overseeing accounting and financial reporting and supporting the company through its acquisition by Novartis. Dina holds an MBA in Professional Accounting from the University of Texas at San Antonio and a BA in Accounting from St. Mary’s University.

Scroll to Top